President’s opioid commission to discuss pain management and medication diversion

APA weighs in with response to commission’s interim report.  

On September 27, the President’s Commission on Combating Drug Addiction and the Opioid Crisis will hold its third public meeting, which will be livestreamed via the Office of National Drug Control Policy website at 12:30 p.m. Eastern (see also White House Live).  The meeting will consist of statements to the commission from government, nonprofit, and business organizations on the topic “Innovative Pain Management and Prevention Measures for Diversion,” followed by discussion of the issues raised.

The American Psychological Association has already weighed in on the science and practice of pain management (among other issues) in a response to the commission’s Draft Interim Report. 

APA has been active on the opioid crisis throughout the year.  In February, it arranged for psychologist Lisa Marsch (Dartmouth College) to present her research on patterns of heroin and synthetic drug use at a briefing for the House of Representatives’ Bipartisan Heroin Task Force.  Her work has focused on fentanyl overdoses in New Hampshire, which has one of the highest rates of opioid overdoses in the U.S.   She spoke on a panel that included Nora Volkow, director of the National Institute on Drug Abuse.

In July, the National Academy of Medicine released a report on "Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use."  Among the members of the committee that produced the report was Sandra Comer (Columbia Univ.), who was nominated by APA.

And, as reported previously, APA staff organized a Capitol Hill briefing on July 25 on “Preventing Opioid Use Disorders: Community Based Approaches that Work,” sponsored by the Friends of NIDA coalition.

For more information on APA’s work on the opioid crisis, contact Geoff Mumford of APA’s Science Government Relations Office.